Hyoscine Butylbromide impurity reference standards are used by pharmaceutical quality-control laboratories, contract research organisations, and generic drug manufacturers to identify, quantify, and control Hyoscine Butylbromide-related impurities during analytical method development, method validation, and regulatory filing. As a antispasmodic (Scopolamine Butylbromide), Hyoscine Butylbromide requires precise characterisation of its process impurities, degradation products, and related substances to meet European Pharmacopoeia (EP), United States Pharmacopeia (USP), and British Pharmacopoeia (BP) monograph requirements. Allmpus Laboratories manufactures and supplies a comprehensive library of Hyoscine Butylbromide impurity standards, each provided with a Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS). All products are held in-stock for rapid dispatch and are suitable for use in ANDA and DMF regulatory submissions.
Chemical Name: (1R,2R,4S,5S,7s,9r)-9-Butyl-7-[[(2S)-3-h...
CAS No:
149-64-4
Molecular Formula: C21H30BrNO4
Molecular Weight: 440.37
CAT No:
ALL-HYB-644
Keywords: Hyoscine Butylbromide
Inventory Status:IN STOCK
Chemical Name: (1R,2R,4S,5S,7S)-9-Methyl-3-oxa-9-azatri...
CAS No:
6533-68-2
Molecular Formula: C17H28BrNO7
Molecular Weight: 438.31
CAT No:
ALL-HYB-682
Keywords: Hyoscine Butylbromide EP Impurity A
Inventory Status:IN STOCK
Chemical Name: α-(Hydroxymethyl)benzeneacetic acid
CAS No:
552-63-6
Molecular Formula: C9H10O3
Molecular Weight: 166.17
CAT No:
ALL-HYB-636
Keywords: Hyoscine Butylbromide EP Impurity B
Inventory Status:IN STOCK
Chemical Name: (1R,2R,4S,5S,7s)-7-[[(2S)-3-Hydroxy-2-ph...
CAS No:
155-41-9
Molecular Formula: C18H24BrNO4
Molecular Weight: 398.29
CAT No:
ALL-HYB-419
Keywords: Hyoscine Butylbromide EP Impurity C
Inventory Status:IN STOCK
Chemical Name: (1R,2R,4S,5S,7s,9r)-7-[[(2S)-3-Hydroxy-2...
CAS No:
N.A.
Molecular Formula: C20H28BrNO4
Molecular Weight: 426.34
CAT No:
ALL-HYB-001
Keywords: Hyoscine Butylbromide EP Impurity D
Inventory Status:IN STOCK
Chemical Name: (1R,2R,4S,5S,7s)-9-Butyl-3-oxa-9-azatric...
CAS No:
22235-98-9
Molecular Formula: C20H28ClNO4
Molecular Weight: 381.89
CAT No:
ALL-HYB-989
Keywords: Hyoscine Butylbromide EP Impurity E
Inventory Status:IN STOCK
Chemical Name: (1R,2R,4S,5S,7s,9s)-9-Butyl-7-[[(2S)-3-h...
CAS No:
N.A.
Molecular Formula: C21H30BrNO4
Molecular Weight: 440.37
CAT No:
ALL-HYB-002
Keywords: Hyoscine Butylbromide EP Impurity F
Inventory Status:IN STOCK
Chemical Name: (1R,2R,4S,5S,7s,9r)-9-Butyl-9-methyl-7-[...
CAS No:
92714-23-3
Molecular Formula: C21H28BrNO3
Molecular Weight: 422.36
CAT No:
ALL-HYB-233
Keywords: Hyoscine Butylbromide EP Impurity G
Inventory Status:IN STOCK
Tropane alkaloid impurities present specific synthetic and analytical challenges due to their bicyclic ring stereochemistry, quaternary nitrogen centers, and the structural overlap between hyoscine butylbromide and its related compounds-hyoscine, hyoscyamine, ipratropium, and tropicamide-several of which share identical or closely related impurities. Allmpus Laboratories' synthetic and analytical chemistry teams operate within R&D and manufacturing facilities accredited by USFDA, EU GMP, EDQM, KFDA, and COFEPRIS, supporting the isolation, synthesis, and structural characterization of alkaloid-class impurities of this type. Standards are intended to be supplied with supporting analytical data-HPLC purity, NMR, and mass spectral confirmation-for direct use in method development, forced-degradation studies, and regulatory documentation. Where a specific EP-listed impurity is not currently in inventory, our teams can undertake custom synthesis on request, including cross-referenced impurities shared with related tropane alkaloid APIs.
Standards are intended to be supplied with a Certificate of Analysis and supporting structural data, typically HPLC purity and spectroscopic confirmation, suitable for method validation and regulatory submissions.
Yes. Given the structural overlap between hyoscine butylbromide and related tropane alkaloid APIs, our synthetic chemistry team can address cross-listed impurities on a case-by-case basis.
No. Allmpus impurity standards are supplied strictly for laboratory, research, and analytical use-including method development and stability-indicating assay validation-and are not intended for human consumption or clinical administration.